AUROBINDO PHARMA
Back to Income Statement
|
AUROBINDO PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹25,141 Cr | ₹23,159 Cr | ₹21,137 Cr | ₹19,071 Cr | ₹19,441 Cr |
What is the latest Total Expenditure of AUROBINDO PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹25,141 Cr |
| Mar2025 | ₹23,159 Cr |
| Mar2024 | ₹21,137 Cr |
| Mar2023 | ₹19,071 Cr |
| Mar2022 | ₹19,441 Cr |
How is Total Expenditure of AUROBINDO PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹25,141 Cr | 8.56 | |
| Mar2025 | ₹23,159 Cr | 9.57 | |
| Mar2024 | ₹21,137 Cr | 10.83 | |
| Mar2023 | ₹19,071 Cr | -1.90 | |
| Mar2022 | ₹19,441 Cr | - | |
Compare Total Expenditure of peers of AUROBINDO PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AUROBINDO PHARMA | ₹96,954.9 Cr | 3.2% | 1.1% | 53.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹424,202.0 Cr | 0.5% | -2.9% | 5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹264,141.0 Cr | 5% | 7.2% | 49.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹174,402.0 Cr | -0.5% | -4.5% | 28.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,868.0 Cr | 2.7% | 8.4% | 5.1% | Stock Analytics | |
| CIPLA | ₹111,650.0 Cr | 2.4% | 2.4% | -12.9% | Stock Analytics | |
AUROBINDO PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AUROBINDO PHARMA | 3.2% |
1.1% |
53.2% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses